Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy. (2019)
Attributed to:
Understanding the autoimmune mechanism in idiopathic membranous nephropathy (IMN)
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1056/nejmoa1814427
PubMed Identifier: 31269364
Publication URI: http://europepmc.org/abstract/MED/31269364
Type: Journal Article/Review
Volume: 381
Parent Publication: The New England journal of medicine
Issue: 1
ISSN: 0028-4793